RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.54B
AUM Growth
+$235M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$75.7M
2
+$73.8M
3
+$48.2M
4
EIDX
Eidos Therapeutics, Inc. Common Stock
EIDX
+$44M
5
ECYT
Endocyte, Inc. Common Stock
ECYT
+$24.4M

Top Sells

1
+$127M
2
+$13.3M
3
+$9.37M
4
VKTX icon
Viking Therapeutics
VKTX
+$8.87M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$6.72M

Sector Composition

1 Healthcare 92.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$287M 18.66%
7,512,049
2
$282M 18.31%
4,240,536
3
$95.8M 6.22%
179,296
4
$78M 5.06%
5,649,884
+1,768,091
5
$75.7M 4.92%
+3,702,533
6
$73.8M 4.79%
+3,119,778
7
$64.7M 4.2%
2,830,455
8
$63.4M 4.12%
1,967,148
+346,495
9
$56.3M 3.65%
4,278,796
+1,806,452
10
$54.9M 3.57%
350,933
-2,200
11
$50.6M 3.29%
1,145,268
12
$48.2M 3.13%
+1,541,743
13
$48.2M 3.13%
3,933,489
14
$44M 2.86%
+2,162,671
15
$40M 2.6%
6,984,692
16
$38.3M 2.49%
3,851,808
17
$29M 1.88%
42,307
18
$19.8M 1.29%
900,000
19
$16.3M 1.06%
1,525,000
20
$16.2M 1.05%
2,857,143
21
$14.4M 0.93%
1,121,153
+462,094
22
$11.7M 0.76%
1,441,070
23
$11.4M 0.74%
506,276
24
$10.9M 0.71%
741,647
25
$4.09M 0.27%
2,535
1
2